Skip to main content

Month: December 2020

Metacrine Reports Positive Results from Phase 1 Trial of MET642

MET642 Demonstrated Sustained Pharmacokinetic Profile and Robust FXR Target Engagement with Once-Daily Oral Dosing, without Pruritis or LDL-Cholesterol IncreaseDoses Selected for Phase 2a Trial in Patients with NASH; On-Track to Initiate in 1H21SAN DIEGO, Dec. 17, 2020 (GLOBE NEWSWIRE) — Metacrine, Inc. (Nasdaq: MTCR), a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases, today reported preliminary results from its Phase 1 trial of MET642, a farnesoid X receptor (FXR) agonist being developed for the treatment of non-alcoholic steatohepatitis (NASH) and inflammatory bowel disease. Findings show that treatment with MET642 was safe and generally well-tolerated and demonstrated a sustained pharmacokinetic (PK) profile and robust...

Continue reading

Zynerba Pharmaceuticals Provides Regulatory Update on Zygel™ in Fragile X Syndrome

– Single Trial to be Conducted in Patients with Fragile X Syndrome to Confirm Positive Results Seen in the Population of Responders in the CONNECT-FX Trial –– Conference Call and Webcast Today, December 17, 2020 at 8:30 am ET –DEVON, Pa., Dec. 17, 2020 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today provided an update on its meeting with the U.S. Food and Drug Administration (FDA) regarding its Fragile X syndrome (FXS) program. The Company plans to conduct a double-blind, placebo-controlled pivotal trial in patients with FXS who have a highly methylated FMR1 gene to confirm the positive results observed in this population of responders in the CONNECT-FX...

Continue reading

Global WholeHealth Partners Corp (OTC: GWHP) Has Paid Off One of Its Outstanding Convertible Notes

Eliminating one of the convertible notes represents a significant milestone for Global WholeHealth Partners Corp.San Clemente, CA, Dec. 17, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Global WholeHealth Partners Corp (OTC: GWHP), has paid off one of its outstanding convertible notes. The note was paid from a direct equity investment by a healthcare investor.Eliminating one of the convertible notes represents a significant milestone for Global WholeHealth Partners Corp, as now Global will seek capital from longer term investments. Since the note was not converted into shares under the original terms, we were also able to avoid substantial dilution to our shareholders.Given our outlook for strong growth this year and the rapidly improving fundamentals of the business, Global is getting into a position where we hopefully can fund...

Continue reading

Worthington Reports Second Quarter Fiscal 2021 Results

COLUMBUS, Ohio, Dec. 17, 2020 (GLOBE NEWSWIRE) — Worthington Industries, Inc. (NYSE: WOR) today reported net sales of $731.1 million and a net loss of $74.0 million, or $(1.40) per diluted share, for its fiscal 2021 second quarter ended November 30, 2020. In the second quarter of fiscal 2020, the Company reported net sales of $827.6 million and net earnings of $52.1 million, or $0.93 per diluted share. Results in both the current and prior year quarter were impacted by several unique items, as summarized below, including a combined pre-tax loss of $148.4 million, or $(2.18) per diluted share, in the current quarter related to the Company’s investment in Nikola Corporation (“Nikola”). See Recent Developments below for further information regarding the Company’s investment in Nikola.  (U.S. dollars in millions, except per share amounts)Financial...

Continue reading

SouthGobi to Announce Second Quarter Results of 2020 on December 23, 2020

VANCOUVER, British Columbia, Dec. 17, 2020 (GLOBE NEWSWIRE) — SouthGobi Resources Ltd. (TSX: SGQ, HK: 1878) (“SouthGobi” or the “Company”) announces that the board of directors will approve the financial results of the Company and its subsidiaries for the second quarter of 2020 on Wednesday, December 23, 2020. These results will be released on Wednesday, December 23, 2020.CONTINUED SUSPENSION OF TRADINGTrading in the common shares of the Company on the TSX and Hong Kong Stock Exchange has been suspended since June 19, 2020 and August 17, 2020 respectively and will remain suspended until further notice.About SouthGobiSouthGobi, listed on the Toronto and Hong Kong stock exchanges, owns and operates its flagship Ovoot Tolgoi coal mine in Mongolia. SouthGobi produces and sells coal to customers in China.Contact:Investor RelationsWebsite:...

Continue reading

ArcAroma AB: 201217 ArcAroma utses till ett FoodTech 500-bolag för 2020

Pressmeddelande 2020-12-17ArcAroma har nyligen valts ut som ett av de företag som ingår i listan FoodTech 500 inom Agrifoodtech 2020. FoodTech 500 är en lista över de femhundra främsta startup- och tillväxtföretag som utvecklar framtidens livsmedel. Med inspiration från Fortune 500 skapade foodtech- och konsultbolaget Forward Fooding världens första globala lista över lovande entreprenörer som verkar i gränslandet mellan livsmedel, teknik och hållbarhet.”Vi är stolta över utnämningen att ingå i FoodTech 500. Detta är en bekräftelse på vår innovativa position för framtida livsmedelsproduktion där vi bidrar med ökad effektivitet, bättre kvalitet och längre hållbarhet”, säger Johan Möllerström, VD i ArcAroma.Med 2052 sökande från över 60 länder representerar FoodTech 500 en otrolig variation av bolag som arbetar med högkvalitativ livsmedelsförsörjning...

Continue reading

ArcAroma AB: 201217 ArcAroma qualifies as a FoodTech 500-company in 2020

Press release 2020-12-17ArcAroma have recently been selected as one of the companies to join The FoodTech 500 of Agrifoodtech in 2020. The FoodTech 500 is a list of the top five hundred startup and scaleup companies shaping the future of food. Inspired by the Fortune 500, the food tech data and consulting company Forward Fooding created the world´s first definitive list of global entreprenurial talent at the intersection between food, technology and sustainability.“We are proud to be part of the FoodTech 500. This is a confirmation of our innovative position for future food production where we contribute with increased efficiency, better quality and extended shelf life”, says Johan Möllerström, CEO ArcAroma.With 2052 applicants from over 60 countries, this year’s FoodTech 500 has revealed an incredibly diverse set of applicants who...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.